38323747|t|Investigating alpha-synuclein co-pathology in Alzheimer's disease by means of cerebrospinal fluid alpha-synuclein seed amplification assay.
38323747|a|INTRODUCTION: Lewy body disease, a frequently observed co-pathology in Alzheimer's disease (AD), can be identified antemortem in cerebrospinal fluid (CSF) by alpha-synuclein seed amplification assay (alphaS-SAA). The prevalence and clinical impact of CSF alphaS-SAA positivity in AD are still unknown. METHODS: alphaS-SAA was performed on CSF samples from 240 AD patients (preclinical, prodromal, and dementia stages), 85 controls, 84 patients with Parkinson's disease (PD), and 21 patients with PD with dementia or dementia with Lewy bodies. In AD patients, associations between alphaS-SAA positivity and cognitive changes were also evaluated. RESULTS: In agreement with available neuropathological studies, alphaS-SAA positivity was observed in 30% of AD patients (vs 9% in controls), and was associated with cognitive decline, visuospatial impairment, and behavioral disturbances. DISCUSSION: alphaS-SAA positivity in AD patients reflects the prevalence observed in neuropathological series and is associated with a worse clinical outcome. These data confirm the validity of CSF alphaS-SAA positivity as biomarker of synucleinopathy.
38323747	14	29	alpha-synuclein	Gene	6622
38323747	46	65	Alzheimer's disease	Disease	MESH:D000544
38323747	98	113	alpha-synuclein	Gene	6622
38323747	154	171	Lewy body disease	Disease	MESH:D020961
38323747	211	230	Alzheimer's disease	Disease	MESH:D000544
38323747	232	234	AD	Disease	MESH:D000544
38323747	298	313	alpha-synuclein	Gene	6622
38323747	347	350	SAA	Gene	6287
38323747	395	402	alphaS-	Gene	112935892
38323747	402	405	SAA	Gene	6287
38323747	420	422	AD	Disease	MESH:D000544
38323747	458	461	SAA	Gene	6287
38323747	500	502	AD	Disease	MESH:D000544
38323747	503	511	patients	Species	9606
38323747	541	549	dementia	Disease	MESH:D003704
38323747	575	583	patients	Species	9606
38323747	589	608	Parkinson's disease	Disease	MESH:D010300
38323747	610	612	PD	Disease	MESH:D010300
38323747	622	630	patients	Species	9606
38323747	636	638	PD	Disease	MESH:D010300
38323747	644	652	dementia	Disease	MESH:D003704
38323747	656	681	dementia with Lewy bodies	Disease	MESH:D020961
38323747	686	688	AD	Disease	MESH:D000544
38323747	689	697	patients	Species	9606
38323747	720	727	alphaS-	Gene	112935892
38323747	727	730	SAA	Gene	6287
38323747	856	859	SAA	Gene	6287
38323747	894	896	AD	Disease	MESH:D000544
38323747	897	905	patients	Species	9606
38323747	951	968	cognitive decline	Disease	MESH:D003072
38323747	970	993	visuospatial impairment	Disease	MESH:D000377
38323747	999	1022	behavioral disturbances	Disease	MESH:D001523
38323747	1043	1046	SAA	Gene	6287
38323747	1061	1063	AD	Disease	MESH:D000544
38323747	1064	1072	patients	Species	9606
38323747	1229	1232	SAA	Gene	6287
38323747	1260	1275	synucleinopathy	Disease	MESH:D000080874
38323747	Positive_Correlation	MESH:D003072	6287
38323747	Association	MESH:D000544	6287
38323747	Positive_Correlation	MESH:D000377	6287
38323747	Association	MESH:D000544	112935892
38323747	Association	MESH:D000544	6622
38323747	Association	MESH:D020961	6287
38323747	Positive_Correlation	MESH:D001523	6287
38323747	Association	MESH:D000080874	6287

